TNF-alpha is a cytokine produced primarily by immune cells and fat tissue that orchestrates inflammatory responses. It's named for its ability to cause tumor cell death in laboratory settings, though its broader role is coordinating immune responses to infection and injury.
Elevated TNF-alpha drives chronic inflammation and is central to conditions like rheumatoid arthritis, inflammatory bowel disease, and metabolic syndrome. Unlike CRP, which is downstream, TNF-alpha is upstream. It triggers the inflammatory cascade rather than just reflecting it. Obesity is a major driver of elevated TNF-alpha through adipose tissue inflammation, and weight loss often meaningfully reduces levels. This marker is less commonly ordered outside specific autoimmune workups but informative for understanding upstream inflammatory drivers.
Optimal TNF-alpha: 0-4 pg/mL.
Typically re-tested every 8 weeks.
TNF-alpha is a pro-inflammatory cytokine, a small messenger protein that immune cells release to start and amplify an inflammatory response.
It is produced mainly by activated macrophages, and also by T cells, natural killer cells and fat tissue. Once released, it binds to two receptors on the surface of other cells, TNFR1 and TNFR2. That binding sets off intracellular signalling, most notably through the NF-kB pathway, which turns on genes for other inflammatory messengers, adhesion molecules that let white blood cells stick to vessel walls, and enzymes that remodel tissue. In short, TNF-alpha is an early alarm signal. It recruits reinforcements, raises local blood flow and makes tissue permeable so immune cells can reach a problem.
That alarm is useful. During acute bacterial infection, cytokine levels rise sharply, and TNF-alpha has been studied as part of biomarker panels used to help distinguish bacterial from other causes of illness[1]. The same signalling also participates in normal tissue repair and in the immune surveillance that clears damaged cells.
The difference that matters for a health optimization panel is not the acute spike. It is the low, persistent background level that can sit slightly elevated for years without any obvious illness. That background level is what a blood test is trying to capture, usually by a sensitive immunoassay on serum or plasma, reported in picograms per millilitre (pg/mL).
It matters because chronic low-grade inflammation is one of the common threads running through metabolic, musculoskeletal and mood-related health, and TNF-alpha sits near the top of that signalling cascade.
Muscle is one of the clearest examples. A systematic review and meta-analysis found that higher circulating inflammatory markers, including TNF-alpha, are associated with sarcopenia, the age-related loss of muscle mass and function[2]. A separate meta-analysis of inflammation and muscle reported that higher inflammatory marker levels are associated with lower muscle strength and mass in older adults[3]. These are associations rather than proof of cause, but they are consistent, and they line up with what TNF-alpha does biologically, which includes promoting muscle protein breakdown.
Metabolic health is another. Fat tissue, particularly visceral fat, secretes TNF-alpha, and research has examined inflammatory and metabolic markers together in conditions such as polycystic ovarian syndrome, where altered inflammatory signalling is frequently reported alongside insulin resistance[4].
Mood and cognition round out the picture. A meta-analysis of 82 studies found that peripheral cytokine levels differ in people with depression compared with controls[5], and a more recent review examined whether that inflammation and depression link differs between men and women[6]. None of this makes an inflammatory marker a test for depression. It does mean that persistent low-grade inflammation is worth understanding rather than ignoring.
In most healthy adults, circulating TNF-alpha is very low, and a typical lab reference range sits below roughly 8 pg/mL.
| Marker | Typical lab reference range | FitScript optimal range |
|---|---|---|
| TNF-alpha (serum or plasma) | 0 to 8 pg/mL | 0 to 4 pg/mL |
In 728 healthy adults aged 20 to 79 in eastern China, TNF-alpha showed no meaningful difference between men and women or across age groups, so the study set one range for everyone.[13]
| Sex | Age | Reference range (pg/mL) |
|---|---|---|
| Men and women | 20 to 79 | 0.60 to 4.89 |
The study checked for differences by sex and by age and found none, which is why there is a single row.[13] It measured TNF-alpha by flow cytometry, and results from other methods are not interchangeable, so your own lab's printed range is the one to read your result against.
Reference ranges vary by lab, assay method, age and sex, so always read your result against the range printed on your own report. The optimal range shown here is FitScript's optimization target, not a diagnostic cut-off, and no single value defines your health. Because assays differ, results from two different laboratories are not directly comparable, which is why tracking the same marker on the same method over time is more informative than one number in isolation.
A result above the lab reference range suggests active or ongoing inflammatory signalling, and the useful question is what is driving it rather than what it proves.
What people report. Symptoms that often travel with chronic low-grade inflammation are non-specific, including persistent fatigue, slower recovery from training, joint aches or morning stiffness, disturbed sleep, low mood and a general sense of running flat. Many people with a mildly raised result feel nothing at all, which is precisely why it is measured.
Common contributors. An acute or recent infection will push cytokine levels up temporarily. Higher body fat, especially around the abdomen, is a recognised source of inflammatory signalling because fat tissue itself secretes TNF-alpha. Autoimmune and inflammatory conditions such as rheumatoid arthritis, psoriasis and inflammatory bowel disease are associated with increased TNF-alpha activity. Poor sleep, smoking, heavy alcohol use, untreated gum disease, high training loads without recovery and significant psychological stress are all plausible contributors.
Why it is worth following up. Sustained elevation is associated with insulin resistance, loss of muscle mass and strength[3], and with the inflammatory component of cardiometabolic risk. A single raised value does not diagnose anything. A raised value that persists across repeat testing, especially with symptoms or other elevated inflammatory markers, is worth discussing with a clinician promptly so the underlying driver can be identified. Never treat an out-of-range result as something to ignore.
A low or undetectable result is usually unremarkable and often reassuring, because healthy circulating levels are naturally near the bottom of the assay's measuring capability.
What people report. There is no recognised symptom pattern that corresponds to low circulating TNF-alpha. People with low results generally feel the way they otherwise feel, and the marker is not used to assess immune strength.
Common explanations. The most common is simply that there is no significant inflammatory activity to detect. Assay sensitivity also matters, since some methods cannot resolve differences at the very low end and report a result as below the limit of detection. Biologic therapies that specifically block TNF-alpha are established treatments in conditions such as inflammatory bowel disease, where drug and antibody levels are monitored to guide care[7]. If you take any of these, your result should be read in that context, and a licensed provider is the one who evaluates whether such a therapy is appropriate in the first place.
What it means long term. A low result on its own does not predict immune weakness or infection risk, and it is not something to try to raise. It is best read as one normal data point within a broader inflammatory picture. If you feel unwell despite a low result, that symptom still deserves clinical attention, because this cytokine is not sensitive enough to rule out every inflammatory process.
Several things shift this marker, some of them to do with how and when blood was drawn rather than with your underlying health.
Testing conditions. Cytokine levels follow a daily rhythm and can differ between a morning and an evening draw, so consistent timing helps when comparing results over time. Sample handling matters too, since delayed processing, the choice of serum versus plasma and repeated freeze-thaw cycles can all affect the measured value. A recent cold, flu, dental infection, vaccination or injury can raise levels for days. A very hard training session shortly before the draw can do the same transiently.
Medications and health conditions. Anti-inflammatory and immune-modulating medicines can lower measured levels. Active autoimmune disease, poorly controlled blood sugar and substantial visceral adiposity tend to push levels the other way. Pregnancy, menopause and significant hormonal shifts also alter inflammatory signalling.
Habits and nutrition, hedged honestly. Exercise is the best-supported lever. A trial in middle-aged and older women with type 2 diabetes reported favourable changes in inflammatory factors and heart rate variability following combined aerobic and resistance training[8]. Gut barrier integrity may play a role, and a systematic review and meta-analysis of randomized trials suggests probiotics can support intestinal barrier function[9]. Among supplements, omega-3 fatty acids have been studied for their effect on blood fatty acid profiles and inflammation, with the EPA to DHA ratio examined as a variable[10], coenzyme Q10 has been evaluated in a GRADE-assessed meta-analysis of inflammation-related biomarkers[11], and berberine has been studied for its effect on metabolic profiles in type 2 diabetes[12]. These findings are associations and averaged effects, not promises about your own number, and no amounts or schedules are given here. Sleep quality, stopping smoking and reducing visceral fat are the unglamorous levers that tend to matter most.
It is measured as part of inflammation-focused blood testing, then interpreted in context rather than read as a standalone number.
FitScript is a labs-first membership built on 150+ biomarkers tested per year, which means a cytokine like this is measured alongside the other inflammatory, metabolic and hormonal markers that give it meaning. A single value tells you very little. The same value seen twice, three months apart, alongside a stable or rising C-reactive protein and a changing body composition, tells you something worth acting on.
Atlas, the AI health advisor, reads the full panel together and writes your FitScript, the personalized output generated from your own biology. The pattern Atlas is looking for is not one outlier. It is whether several inflammatory markers move together, whether the trend is improving, and which lifestyle or clinical questions that pattern raises.
Where a result suggests something clinical, a licensed provider reviews the member and decides whether any treatment is appropriate. No prescription therapy is recommended, dosed or started on the basis of a biomarker article, and none should be.
Inflammation is a network, so this cytokine is most informative when read next to the markers it influences and the ones that influence it.
Interleukin-6 is the cytokine most closely downstream, often rising in parallel and driving the liver's acute-phase response. C-Reactive Protein is that acute-phase protein itself, cheaper, more stable and the usual first-line measure of systemic inflammation. ESR gives a slower, broader signal of inflammatory activity and is useful for tracking change over weeks. Fibrinogen Activity connects inflammation to clotting and vascular risk. Leptin reflects fat mass and appetite signalling, which matters because adipose tissue is itself a source of inflammatory cytokines. Homocysteine adds a separate vascular and methylation angle that frequently travels with inflammatory patterns. Together these sit within an Advanced Inflammation panel, which is how the full picture is usually assembled.
Read it as one line in a paragraph, not the whole story. Observe the number, consider what might reasonably explain it, retest under consistent conditions before drawing conclusions, and bring persistent or unexplained findings to a clinician.
This article is educational and is not medical advice. Discuss your results and any treatment options with a clinician or licensed provider who can review your full history.
It measures the concentration of tumour necrosis factor alpha circulating in your blood, usually reported in picograms per millilitre. Because the protein has a short half-life and sits at very low levels in healthy people, the test uses a sensitive immunoassay. It reflects inflammatory signalling at the moment of the draw rather than your inflammatory history.
No. TNF-alpha is an upstream cytokine released by immune cells to start inflammation, while C-reactive protein is a downstream acute-phase protein made by the liver in response to that signalling. CRP is more stable and more widely used as a first-line measure. The two are complementary, which is why inflammation panels often include both.
No single value diagnoses a condition. A raised result shows inflammatory activity, which could come from a recent infection, poor sleep, higher body fat, heavy training or an inflammatory condition. Interpretation depends on your symptoms, history and other markers, so a persistently raised result is worth discussing with a clinician promptly rather than self-interpreting.
Fasting is not specifically required for this marker, though it is often drawn alongside metabolic markers that do call for it, so follow the instructions on your lab requisition. What helps more is consistency, meaning a similar time of day, no acute illness and no unusually hard training session in the day or two before the draw.
Regular exercise is associated with improvements in inflammatory markers. A single hard session can raise levels transiently, so the pattern that matters is consistent training over months, not one workout before a blood draw.
Supplements such as omega-3 fatty acids and coenzyme Q10 have been studied for effects on inflammation-related biomarkers, but whether they help is not settled. No amounts or schedules are given here, and supplements interact with medications and conditions. Discuss any supplement with a clinician who can review your full picture before you start.
Typical lab reference ranges place healthy adults below roughly 8 pg/mL, and FitScript's optimal range is 0 to 4 pg/mL. The optimal range is an optimization target rather than a diagnostic cut-off. Ranges vary by lab, assay, age and sex, so read your value against the range on your own report and track the trend over time.
Because levels fluctuate with acute illness, sleep and training load, a single reading is rarely conclusive. Retesting after a meaningful interval, typically once changes to training, body composition or sleep have had time to take effect, gives a more useful trend. Your clinician can advise on timing based on why the marker was measured in the first place.